Search

Date 2022 Author/Creator Fowler, Nathan

1. Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. Issue 2 (10th January 2022)

Authors:
Jain, Preetesh; Zhao, Shuangtao; Lee, Hun Ju; Hill, Holly A.; Ok, Chi Young; Kanagal-Shamanna, Rashmi; Hagemeister, Fredrick B.; Fowler, Nathan; Fayad, Luis; Yao, Yixin; Liu, Yang; Moghrabi, Omar B.; Navsaria, Lucy; Feng, Lei; Nogueras Gonzalez, Graciela M.; Xu, Guofan; Thirumurthi, Selvi; Santos...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 2(2022)
Page Start:
202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial. Issue 3 (March 2022)

Authors:
Wang, Michael L; Jain, Preetesh; Zhao, Shuangtao; Lee, Hun Ju; Nastoupil, Loretta; Fayad, Luis; Ok, Chi Young; Kanagal-Shamanna, Rashmi; Hill, Holly A; Yao, Yixin; Hagemeister, Fredrick B; Westin, Jason R; Fowler, Nathan; Samaniego, Felipe; Steiner, Raphael; Nair, Ranjit; Iyer, Swaminathan P; Nav...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 3(2022)
Page Start:
406
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search